Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Receivables for 16 consecutive years, with $8.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables fell 6.28% year-over-year to $8.3 million, compared with a TTM value of $8.3 million through Sep 2025, down 6.28%, and an annual FY2024 reading of $8.3 million, down 23.94% over the prior year.
  • Receivables was $8.3 million for Q3 2025 at Rockwell Medical, up from $8.1 million in the prior quarter.
  • Across five years, Receivables topped out at $16.2 million in Q2 2022 and bottomed at $5.4 million in Q2 2021.
  • Average Receivables over 5 years is $8.7 million, with a median of $8.3 million recorded in 2024.
  • The sharpest move saw Receivables soared 202.03% in 2022, then plummeted 66.56% in 2023.
  • Year by year, Receivables stood at $5.9 million in 2021, then rose by 5.85% to $6.3 million in 2022, then soared by 74.17% to $10.9 million in 2023, then dropped by 23.94% to $8.3 million in 2024, then rose by 0.45% to $8.3 million in 2025.
  • Business Quant data shows Receivables for RMTI at $8.3 million in Q3 2025, $8.1 million in Q2 2025, and $9.7 million in Q1 2025.